D-0180-2021 Class III Terminated
FDA drug recall D-0180-2021 was initiated by Strides Pharma Inc. on December 22, 2020 and is designated Class III. Reason for recall: Failed Moisture Limits The recall status is terminated (terminated January 26, 2022). Affected quantity: 960 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- January 6, 2021
- Initiation Date
- December 22, 2020
- Termination Date
- January 26, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 960 bottles
Product Description
NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816
Reason for Recall
Failed Moisture Limits
Distribution Pattern
PA
Code Information
Lot 7242728A; June 2023